attachment
attachment

Explain the reports

Reading File
analyse_media
Finding Sources
Finding Sources
Searching PubMed

"esophageal squamous cell carcinoma" AND "microinvasive"

Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Reading File
Finding Sources
I now have all the information needed to provide a thorough, clear explanation of this report. Let me compose the answer.

Histopathology Report Explained - Mrs. Ambika S. Gadgi

Patient Summary

DetailValue
NameMrs. Ambika S. Gadgi
Age / Sex55 years, Female
Referred byDr. Jalil Mujawar (MS, ENT)
Date24-07-2026
Report No.HPR 752/26

What Was Biopsied?

A small tissue sample (biopsy) was taken from a lesion in the food pipe (esophagus), located 35 cm from the front teeth. This measurement places it in the lower mid to distal esophagus. Multiple tiny gray-white tissue fragments (0.5 cm each) were sent to the lab and processed into a single block for microscopic examination.

What the Microscope Found (Plain Language)

The pathologist examined the tissue under the microscope and found the following:

1. Stratified Squamous Epithelium with Severe Dysplasia to Carcinoma in Situ

The inner lining of the esophagus is normally made of squamous cells (flat, layered cells). In this biopsy, these cells showed severe dysplasia - meaning the cells have lost their normal structure and organization. "Carcinoma in situ" means the cancer cells are present throughout the full thickness of the lining layer, but have not yet deeply invaded the tissue beneath. This is essentially a pre-invasive or very early cancer stage.
As shown in this histology reference image from the medical literature:
Histologic grades of esophageal squamous dysplasia - A: Normal, D: Mild dysplasia (lower 1/3), E: Moderate dysplasia (lower 2/3), F: Severe dysplasia involving all layers of the epithelium
This image shows the spectrum from normal squamous epithelium (A) through mild (D), moderate (E), and severe dysplasia/carcinoma in situ (F).

2. Abnormal Cell Features

The individual cancer cells show classic malignant features:
  • Pleomorphic nuclei: cells are irregular and vary in size/shape (not uniform like normal cells)
  • Hyperchromatic nuclei: the cell nuclei stain very dark, indicating abnormal DNA content
  • Prominent nucleoli: the "control center" within the nucleus is enlarged and visible
  • Eosinophilic cytoplasm: the cell body stains pink, consistent with squamous differentiation
  • High N:C ratio: the nucleus is disproportionately large relative to the cell body - a hallmark of malignancy

3. Foci of Microinvasion

This is the most critical finding. "Foci of tumor microinvasion into subepithelial tissue" means that in a few small spots, the cancer cells have broken through the basement membrane and begun to creep into the tissue just beneath the surface lining. This is what distinguishes microinvasive from purely in-situ (non-invasive) carcinoma.

4. Lymphocyte Infiltration

The scanty surrounding connective tissue (stroma) shows diffuse infiltration by lymphocytes - these are immune cells (white blood cells) that the body has sent to fight the abnormal cells. This is a typical immune response to early cancer.

Final Diagnosis: Microinvasive Squamous Cell Carcinoma

This is an early-stage esophageal squamous cell carcinoma (ESCC). It sits on the border between carcinoma in situ (pre-invasive) and frankly invasive cancer. According to Sleisenger & Fordtran's Gastrointestinal and Liver Disease, ESCC is the most common form of esophageal cancer worldwide, particularly prevalent in Asia and Africa, and more common in women in high-incidence regions (approaching a 1:1 male-to-female ratio). The risk of progression from severe dysplasia/carcinoma-in-situ is very high - one long-term cohort study found a relative risk of 34.4x for carcinoma in situ progressing to invasive cancer (Clinical Gastrointestinal Endoscopy, 3rd ed.).

Why Was This Sent to an ENT Surgeon?

The patient was referred by an ENT (Ear-Nose-Throat) surgeon. ENT specialists manage lesions of the upper aerodigestive tract, including the upper esophagus and throat. A 35 cm lesion is typically in the mid-esophagus, but ENT specialists may have been involved in the initial endoscopic evaluation or management of upper esophageal/pharyngeal symptoms.

What Does This Mean for the Patient?

AspectImplication
StageVery early - microinvasive (T1a or early T1b)
PrognosisFavorable if treated promptly
Treatment optionsEndoscopic resection (EMR/ESD) is often curative at this stage; surgery may be discussed
Next stepsUrgent referral to a gastroenterologist/oncologist for staging (endoscopic ultrasound, CT scan) and treatment planning
UrgencyThis is a serious diagnosis requiring prompt action, but the early detection is a significant advantage
Important note for the patient/family: This report confirms an early cancer in the food pipe. The word "microinvasive" is actually reassuring - it means the cancer has been caught at a very early stage where treatment is most likely to succeed. The next step is to see an oncologist or gastroenterologist urgently for staging investigations (CT scan, endoscopic ultrasound) and to plan treatment. Do not delay.

How operation works give me some photos operation

Finding Sources
Finding Sources
Searching Images

endoscopic submucosal dissection ESD esophageal squamous carcinoma procedure steps

A multi-panel clinical image depicting an endoscopic submucosal dissection (ESD) procedure for metachronous early esophageal squamous cell carcinoma (SCC) in the setting of a pre-existing esophageal stricture. Panel (a) shows an endoscopic view of a severe esophageal stricture with a pinhole-sized lumen and surrounding fibrotic, erythematous mucosa resulting from a previous ESD scar. Panel (b) demonstrates the intraprocedural release of the stricture following mucosal incision and partial submucosal dissection of the lesion at the oral aspect, resulting in a widened lumen. Panel (c) shows the post-procedural ulcer base, characterized by a smooth, denuded surface without visible residual submucosal tissue. Panel (d) displays the en-bloc resected specimen, pinned for pathological examination. The specimen is roughly circular, showing orange-tinted mucosa with distinct dark-stained areas (likely from Lugol's iodine staining) identifying the squamous cell carcinoma lesion. This series illustrates the successful management of complex esophageal lesions located within fibrotic strictures using conventional endoscopic techniques.

A multi-panel clinical image depicting an endoscopic submucosal dissection (ESD) procedure for metachronous early esophageal squamous cell carcinoma (SCC) in the setting of a pre-existing esophageal stricture. Panel (a) shows an endoscopic view of a severe esophageal stricture with a pinhole-sized lumen and surrounding fibrotic, erythematous mucosa resulting from a previous ESD scar. Panel (b) demonstrates the intraprocedural release of the stricture following mucosal incision and partial submucosal dissection of the lesion at the oral aspect, resulting in a widened lumen. Panel (c) shows the post-procedural ulcer base, characterized by a smooth, denuded surface without visible residual submucosal tissue. Panel (d) displays the en-bloc resected specimen, pinned for pathological examination. The specimen is roughly circular, showing orange-tinted mucosa with distinct dark-stained areas (likely from Lugol's iodine staining) identifying the squamous cell carcinoma lesion. This series illustrates the successful management of complex esophageal lesions located within fibrotic strictures using conventional endoscopic techniques.

This set of three endoscopic images (A-C) illustrates the sequential stages of an Endoscopic Submucosal Dissection (ESD) procedure for esophageal squamous cell carcinoma. Image A shows the initial pre-cutting phase, where circumferential mucosal incisions are made around the outer border of the target lesion, resulting in visible tissue disruption and minor bleeding. Image B depicts the submucosal dissection phase; an endoscopic knife is visible in the field as it separates the lesion from the muscularis propria, with clear visualization of the submucosal plane. Image C captures the post-procedural state, revealing a large iatrogenic ulcer spanning approximately three-fourths of the esophageal circumference. The ulcer base is irregular, showing exposed submucosa with areas of hyperemic and dark necrotic tissue, characteristic of a comprehensive en bloc resection. This series is an educational example of advanced gastrointestinal therapeutic endoscopy, highlighting the transition from surgical planning to the final iatrogenic defect.

This set of three endoscopic images (A-C) illustrates the sequential stages of an Endoscopic Submucosal Dissection (ESD) procedure for esophageal squamous cell carcinoma. Image A shows the initial pre-cutting phase, where circumferential mucosal incisions are made around the outer border of the target lesion, resulting in visible tissue disruption and minor bleeding. Image B depicts the submucosal dissection phase; an endoscopic knife is visible in the field as it separates the lesion from the muscularis propria, with clear visualization of the submucosal plane. Image C captures the post-procedural state, revealing a large iatrogenic ulcer spanning approximately three-fourths of the esophageal circumference. The ulcer base is irregular, showing exposed submucosa with areas of hyperemic and dark necrotic tissue, characteristic of a comprehensive en bloc resection. This series is an educational example of advanced gastrointestinal therapeutic endoscopy, highlighting the transition from surgical planning to the final iatrogenic defect.

This endoscopic image displays the cervical esophagus during an Endoscopic Submucosal Dissection (ESD) procedure for squamous cell carcinoma. The primary focus is a depressed, irregular lesion within the esophageal lumen, which has been demarcated by white, ring-shaped circumferential thermal markings. These cautery spots define the resection margins. The mucosal tissue appears erythematous and edematous, consistent with inflammatory changes. At approximately the 10 o'clock position, a distinct mucosal defect or superficial ulceration is visible, characterized by a pale, granular base and slightly raised, irregular borders. Small focal areas of petechiae and subepithelial hemorrhage are noted on the surrounding pinkish mucosa. The image is captured through a transparent distal attachment (hood), facilitating better visualization of the esophageal folds and the anatomical depth of the depressed region. This visual serves as an educational example of preoperative lesion mapping and endoscopic site preparation in a patient with a complex anatomical history involving previous surgery and radiotherapy.

This endoscopic image displays the cervical esophagus during an Endoscopic Submucosal Dissection (ESD) procedure for squamous cell carcinoma. The primary focus is a depressed, irregular lesion within the esophageal lumen, which has been demarcated by white, ring-shaped circumferential thermal markings. These cautery spots define the resection margins. The mucosal tissue appears erythematous and edematous, consistent with inflammatory changes. At approximately the 10 o'clock position, a distinct mucosal defect or superficial ulceration is visible, characterized by a pale, granular base and slightly raised, irregular borders. Small focal areas of petechiae and subepithelial hemorrhage are noted on the surrounding pinkish mucosa. The image is captured through a transparent distal attachment (hood), facilitating better visualization of the esophageal folds and the anatomical depth of the depressed region. This visual serves as an educational example of preoperative lesion mapping and endoscopic site preparation in a patient with a complex anatomical history involving previous surgery and radiotherapy.

This composite of clinical endoscopic images illustrates the procedural steps for the endoscopic submucosal dissection (ESD) of subcircumferential superficial esophageal cancer. (a) Conventional endoscopy with Lugol's iodine staining reveals a large, unstained, irregular reddish-orange lesion occupying most of the esophageal circumference, characteristic of superficial squamous cell carcinoma. (b) Magnified narrow-band imaging (NBI) shows the intrapapillary capillary loop (IPCL) patterns used to evaluate depth of invasion; the absence of B2/B3 vessel patterns suggests limited mucosal involvement. (c) Pre-procedural marking of the lesion's boundaries with a Flush knife is visible, accompanied by a submucosal injection of glycerol solution, which causes the target tissue to become distended and pale/translucent. (d) Shows the initial mucosal incisions performed precisely along the marking dots on both sides of the lesion. (e) Demonstrates the final result of the 'Line-and-Branch' (LB) method, highlighting the preservation of healthy remnant mucosa to minimize the risk of post-operative esophageal stricture. This series demonstrates advanced gastroenterological techniques for organ-preserving oncological resection.

This composite of clinical endoscopic images illustrates the procedural steps for the endoscopic submucosal dissection (ESD) of subcircumferential superficial esophageal cancer. (a) Conventional endoscopy with Lugol's iodine staining reveals a large, unstained, irregular reddish-orange lesion occupying most of the esophageal circumference, characteristic of superficial squamous cell carcinoma. (b) Magnified narrow-band imaging (NBI) shows the intrapapillary capillary loop (IPCL) patterns used to evaluate depth of invasion; the absence of B2/B3 vessel patterns suggests limited mucosal involvement. (c) Pre-procedural marking of the lesion's boundaries with a Flush knife is visible, accompanied by a submucosal injection of glycerol solution, which causes the target tissue to become distended and pale/translucent. (d) Shows the initial mucosal incisions performed precisely along the marking dots on both sides of the lesion. (e) Demonstrates the final result of the 'Line-and-Branch' (LB) method, highlighting the preservation of healthy remnant mucosa to minimize the risk of post-operative esophageal stricture. This series demonstrates advanced gastroenterological techniques for organ-preserving oncological resection.

Finding Sources
Finding Sources
Searching Images

esophagectomy surgery technique Ivor Lewis diagram

This medical illustration depicts a surgical reinforcement technique following an Ivor Lewis esophagogastrectomy. The diagram shows the intrathoracic positioning of a gastric conduit (marked by a double arrow) in relation to the tracheobronchial tree. An esophagogastric anastomosis is indicated by an asterisk (*). To reinforce a repair of the posterior membranous tracheal wall, the gastric conduit is moved into direct contact with the trachea. Single interrupted nonabsorbable sutures (indicated by a single arrow) are used to secure the gastric wall to the inferior edge of the rigid cartilaginous tracheal rings. This pedagogical image illustrates the use of a vascularized gastric pedicle as a protective flap or 'seal' for tracheal lacerations or patches, demonstrating the anatomical proximity and surgical landmarks relevant to thoracic surgery and complication management in esophagectomy cases.

This medical illustration depicts a surgical reinforcement technique following an Ivor Lewis esophagogastrectomy. The diagram shows the intrathoracic positioning of a gastric conduit (marked by a double arrow) in relation to the tracheobronchial tree. An esophagogastric anastomosis is indicated by an asterisk (*). To reinforce a repair of the posterior membranous tracheal wall, the gastric conduit is moved into direct contact with the trachea. Single interrupted nonabsorbable sutures (indicated by a single arrow) are used to secure the gastric wall to the inferior edge of the rigid cartilaginous tracheal rings. This pedagogical image illustrates the use of a vascularized gastric pedicle as a protective flap or 'seal' for tracheal lacerations or patches, demonstrating the anatomical proximity and surgical landmarks relevant to thoracic surgery and complication management in esophagectomy cases.

This composite of four clinical images illustrates the abdominal phase of a three-port laparoscopic esophagectomy (Ivor Lewis procedure). Image (A) is a clinical photograph of a patient's abdomen showing preoperative markings for port placement: a 10-mm port at the right costal arch, a 15-mm port right lateral to the umbilicus, and a 5-mm port left lateral to the umbilicus. Images (B, C, D) are intraoperative laparoscopic views. Image (B) demonstrates the division of the left gastric vessels using an endoscopic linear vascular stapler, with the liver retracted to expose the celiac axis area. Image (C) illustrates a non-grasping technique using open-jaw retraction with a Babcock clamp to manipulate the stomach and visualize the gastrocolic ligament without tissue trauma. Image (D) shows the final view of the tubularized gastric conduit, characterized by longitudinal staple lines and shiny serosal tissue, prepared for intrathoracic pull-up. The series highlights surgical techniques for vascular control, atraumatic gastric mobilization, and conduit formation in minimally invasive esophageal surgery.

This composite of four clinical images illustrates the abdominal phase of a three-port laparoscopic esophagectomy (Ivor Lewis procedure). Image (A) is a clinical photograph of a patient's abdomen showing preoperative markings for port placement: a 10-mm port at the right costal arch, a 15-mm port right lateral to the umbilicus, and a 5-mm port left lateral to the umbilicus. Images (B, C, D) are intraoperative laparoscopic views. Image (B) demonstrates the division of the left gastric vessels using an endoscopic linear vascular stapler, with the liver retracted to expose the celiac axis area. Image (C) illustrates a non-grasping technique using open-jaw retraction with a Babcock clamp to manipulate the stomach and visualize the gastrocolic ligament without tissue trauma. Image (D) shows the final view of the tubularized gastric conduit, characterized by longitudinal staple lines and shiny serosal tissue, prepared for intrathoracic pull-up. The series highlights surgical techniques for vascular control, atraumatic gastric mobilization, and conduit formation in minimally invasive esophageal surgery.

A medical illustration depicting the surgical setup for a right thoracoscopic approach in an Ivor Lewis esophagectomy. The diagram shows a patient in the left lateral decubitus position with the right arm extended forward. Four surgical trocar port sites are numerically labeled (1-4) on the lateral thoracic wall. Port 1 is positioned anteriorly near the midaxillary line. Port 2 is located inferiorly to port 1. Port 3 is placed superiorly and posteriorly, near the posterior axillary line. Port 4 is situated posteriorly and inferiorly, in proximity to the scapula tip. A brown line connects ports 3 and 1, likely indicating the surgical trajectory or line of esophageal mobilization. This diagram serves as a clinical guide for port placement during minimally invasive esophagectomy, emphasizing the relationship between thoracic landmarks and instrument access points for mediastinal lymphadenectomy and esophageal resection.

A medical illustration depicting the surgical setup for a right thoracoscopic approach in an Ivor Lewis esophagectomy. The diagram shows a patient in the left lateral decubitus position with the right arm extended forward. Four surgical trocar port sites are numerically labeled (1-4) on the lateral thoracic wall. Port 1 is positioned anteriorly near the midaxillary line. Port 2 is located inferiorly to port 1. Port 3 is placed superiorly and posteriorly, near the posterior axillary line. Port 4 is situated posteriorly and inferiorly, in proximity to the scapula tip. A brown line connects ports 3 and 1, likely indicating the surgical trajectory or line of esophageal mobilization. This diagram serves as a clinical guide for port placement during minimally invasive esophagectomy, emphasizing the relationship between thoracic landmarks and instrument access points for mediastinal lymphadenectomy and esophageal resection.

Reading File
Reading File
I now have everything needed for a thorough, image-rich explanation. Here it is:

How the Operations Work for Esophageal Microinvasive Squamous Cell Carcinoma

For Mrs. Ambika's diagnosis, there are two main treatment approaches, chosen based on how deeply the cancer has invaded and the patient's fitness for surgery.

πŸ”¬ OPTION 1: Endoscopic Resection (ESD / EMR) β€” Preferred for Early/Microinvasive Stage

Since the cancer is microinvasive (caught very early), the first-line treatment is usually Endoscopic Submucosal Dissection (ESD) - a procedure done through a flexible tube (endoscope) passed through the mouth. No cuts on the body are needed.

Step-by-Step: How ESD Works

Step 1 - Identify the lesion with Lugol's iodine staining Iodine is sprayed inside the esophagus. Normal cells stain brown; cancer cells remain unstained (orange/pale), clearly marking the area to be removed.
Step 2 - Mark the borders The surgeon marks a ring of tiny dots around the edge of the lesion using a heated endoscopic knife.
ESD Step 1-2: Lugol iodine staining reveals the unstained squamous carcinoma lesion; borders are marked with cautery dots before submucosal injection lifts the tissue
Step 3 - Lift the lesion A liquid (glycerol or saline) is injected into the submucosal layer beneath the lesion to "lift" it away from the deeper muscle wall, creating a safe cushion.
Step 4 - Cut and dissect The surgeon cuts around and under the lesion using a thin endoscopic knife, separating it from the surrounding tissue in one piece (en bloc). This is seen below - the knife is visible cutting through the submucosal layer:
ESD steps A-C: (A) circumferential mucosal incisions around the lesion, (B) endoscopic knife dissecting through the submucosal plane away from the muscle layer, (C) large post-resection ulcer bed after complete en-bloc removal
Step 5 - Remove the specimen The cut piece of tissue is retrieved and pinned flat for the pathologist to examine and confirm clean margins.
ESD of early esophageal SCC: (a) severe stricture from previous ESD scar, (b) lumen widened after incision, (c) smooth post-ESD ulcer base, (d) the en-bloc resected specimen pinned flat showing the cancer lesion stained with Lugol's iodine
Recovery: Patient typically stays 1-3 days in hospital. The raw ulcer left behind heals on its own over 4-6 weeks. Prognosis is excellent if margins are clear.

πŸ₯ OPTION 2: Esophagectomy (Surgical Removal) β€” for Deeper Invasion or Failed Endoscopy

If the tumor is found to be more deeply invasive (after staging) or endoscopic resection cannot achieve clear margins, esophagectomy is done - partial or total removal of the esophagus. The most common type for mid/lower esophageal cancer is the Ivor Lewis esophagectomy.

How Ivor Lewis Esophagectomy Works

The operation has two phases:
Phase 1 - Abdominal phase (laparoscopic/open):
  • The surgeon enters the abdomen and mobilizes the stomach, freeing it from its attachments
  • The stomach is shaped into a long tube ("gastric conduit") using surgical staplers
  • The left gastric blood vessels are divided
Phase 2 - Chest phase (thoracoscopic/open):
  • The surgeon enters the right chest
  • The diseased esophagus is removed
  • The stomach tube is pulled up into the chest and joined (anastomosed) to the remaining esophagus above the tumor
Ivor Lewis laparoscopic abdominal phase: (A) port placement on abdomen, (B) dividing left gastric vessels with stapler, (C) atraumatic stomach retraction, (D) the finished tubular gastric conduit ready to be pulled into the chest
Ivor Lewis thoracoscopic phase: port placement diagram on the right chest wall (4 ports, patient in left lateral position) for esophageal mobilization and mediastinal lymph node removal
According to Goldman-Cecil Medicine, surgery alone can be curative in over 60% of cases for early T1-T2 disease without lymph node involvement.

Which Treatment for Mrs. Ambika?

TreatmentUsed WhenHow Done
ESD (endoscopic)Microinvasive, T1a - PREFERRED at this stageScope through mouth, no incision
EsophagectomyDeeper invasion, failed ESD, T1b or higherMajor surgery, 2-phase operation
ChemoradiationCan't do surgery, cervical location, or advanced stageRadiation + chemotherapy tablets/infusion
Per Current Surgical Therapy 14th edition, for pTis and pT1a squamous cell carcinoma (which matches Mrs. Ambika's microinvasive diagnosis), the recommended treatment is endoscopic resection (ER) with or without ablation, with esophagectomy as a backup. This means she has a good chance of being treated without major open surgery.

Bottom line: Mrs. Ambika's cancer was caught at the ideal stage for endoscopic treatment. The next step is urgent referral to a gastroenterologist or surgical oncologist for endoscopic ultrasound (EUS) staging and ESD planning. The earlier the treatment begins, the better the outcome.

What is the best step what can can I do next step next or chemotherapy or surgery or enscopt

Finding Sources
Finding Sources
Searching PubMed

"esophageal squamous cell carcinoma" AND "early stage" AND treatment

Reading Article

PMID: 37498266

Finding Sources
I now have everything needed - including the latest 2023 ASGE Practice Guideline. Here is the clear, step-by-step answer:

What Is the Best Next Step for Mrs. Ambika?

Short answer: Do NOT start chemotherapy or surgery yet. The immediate next step is proper staging scans - then endoscopic treatment (ESD) is most likely the best option for this early cancer.

The Recommended Pathway - Step by Step

βœ… STEP 1 (Do This First) β€” Staging Investigations

Before any treatment, you must know exactly how deep the cancer has gone and whether it has spread. This is done with 3 tests:
TestWhat It ShowsWhy It Matters
Endoscopic Ultrasound (EUS)Depth of invasion (T stage) and nearby lymph nodesMost important test to decide ESD vs surgery
CT Scan (chest + abdomen)Whether cancer has spread to distant organs or lymph nodesRules out metastasis
PET Scan (optional)Any hidden spread elsewhere in the bodyConfirms no distant disease
The biopsy report says microinvasive - but the exact depth (T1a vs T1b) must be confirmed by EUS before choosing treatment. According to Yamada's Textbook of Gastroenterology, EUS has replaced other methods as the standard for pre-treatment staging of esophageal cancer.

βœ… STEP 2 β€” Endoscopic Treatment (ESD) β€” Most Likely Best Option

Based on the 2023 American Society for Gastrointestinal Endoscopy (ASGE) Practice Guideline (Forbes et al., PMID 37498266):
"For early-stage esophageal squamous cell carcinoma, the ASGE recommends ESD over surgery, whenever possible."
ESD (Endoscopic Submucosal Dissection) is the preferred treatment because:
  • The cancer is still very early (microinvasive)
  • No cuts on the body - scope goes through the mouth
  • Very high cure rate at this stage
  • Faster recovery (1-3 days in hospital vs weeks for surgery)
  • Surgery can still be done later if ESD margins are not clear

Simple Decision Tree

Biopsy confirms microinvasive SCC
            ↓
   STAGING FIRST (EUS + CT scan)
            ↓
   β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
   ↓                 ↓                    ↓
T1a (surface)    T1b (deeper but    T2-T4 or lymph
no lymph nodes   no lymph nodes)    nodes involved
   ↓                 ↓                    ↓
  ESD            ESD or Surgery     Surgery + 
(Preferred)      (Discuss with      Chemoradiation
                  oncologist)       (Before/After)

Why NOT Chemotherapy First?

Chemotherapy alone is NOT used at this early stage. Chemotherapy (combined with radiation) is reserved for:
  • Patients who cannot tolerate surgery
  • More advanced cancers (T3/T4 or lymph node positive)
  • Cervical esophagus location
Starting chemotherapy first for this early microinvasive cancer would be over-treatment and unnecessary.

Summary - What To Do Right Now

PriorityActionWhere to Go
Urgent (this week)See a gastroenterologist + oncologistReferral from Dr. Jalil Mujawar
Within 1-2 weeksGet EUS + CT scan for stagingGI endoscopy centre
After stagingMost likely ESD procedureTertiary hospital with advanced endoscopy
Do NOT do yetSurgery or chemotherapyWait for staging results first
Important: This cancer was caught at the best possible stage. The earlier ESD is done, the higher the chance of complete cure. Please consult a gastroenterologist at a major hospital as soon as possible - ideally within this week.

What is the best step what can can I do next step next or chemotherapy or surgery or enscopt

I already answered this question in detail just above! Here is a quick summary of the key points:

Best Next Steps for Mrs. Ambika (Simple Version)

🚫 Do NOT start chemotherapy or surgery yet


βœ… Do This in Order:

1️⃣ THIS WEEK β€” See a Gastroenterologist + Oncologist
  • Go back to Dr. Jalil Mujawar and ask for urgent referral to a cancer specialist (oncologist) and gastroenterologist at a major hospital
2️⃣ WITHIN 1-2 WEEKS β€” Get Staging Tests
  • Endoscopic Ultrasound (EUS) - checks exact depth of cancer
  • CT Scan (chest + abdomen) - checks if cancer has spread anywhere
  • These tests decide which treatment is best
3️⃣ AFTER STAGING β€” Most Likely ESD (Endoscopic Treatment)
  • Since the cancer is caught very early, the most likely treatment is ESD (Endoscopic Submucosal Dissection) - done through the mouth, no cuts, 1-3 days hospital stay, very high cure rate
  • The 2023 ASGE guideline specifically recommends ESD over surgery for early esophageal squamous cell carcinoma

When Is Each Treatment Used?

TreatmentUsed When
ESD (Endoscopy)Early cancer (most likely for Mrs. Ambika) βœ…
SurgeryCancer is deeper or ESD failed
Chemo + RadiationAdvanced cancer or unfit for surgery

⚠️ The most important thing right now is to NOT delay. Book an appointment at a major hospital cancer centre this week. The cancer is early and highly treatable - but waiting makes it worse. Time matters.

Esd operation photos

Searching Images

ESD endoscopic submucosal dissection esophageal cancer step by step procedure photos

This eight-panel clinical image sequence illustrates a traction-assisted Endoscopic Submucosal Dissection (ESD) procedure for large esophageal cancer. (a) Displays Lugol's iodine chromoendoscopy revealing an unstained neoplastic area with circumferential marking dots. (b) Shows the initial distal (anal) mucosal incision. (c) Demonstrates the completion of circumferential mucosal incisions with trimming of the submucosal edges. (d-f) Illustrate the traction phase, where a metallic clip-with-line is anchored to the oral mucosal edge; pulling the thread provides counter-traction, enhancing visualization of the blue-stained submucosal plane for precise dissection. (g) Visualizes the post-resection esophageal ulcer bed showing clear muscularis propria. (h) Presents the final en bloc resected specimen after ex vivo iodine staining, highlighting the irregular tumor margins for pathological assessment. The sequence serves as a gastrointestinal endoscopy educational resource for advanced therapeutic techniques in managing early-stage esophageal squamous cell carcinoma.

This eight-panel clinical image sequence illustrates a traction-assisted Endoscopic Submucosal Dissection (ESD) procedure for large esophageal cancer. (a) Displays Lugol's iodine chromoendoscopy revealing an unstained neoplastic area with circumferential marking dots. (b) Shows the initial distal (anal) mucosal incision. (c) Demonstrates the completion of circumferential mucosal incisions with trimming of the submucosal edges. (d-f) Illustrate the traction phase, where a metallic clip-with-line is anchored to the oral mucosal edge; pulling the thread provides counter-traction, enhancing visualization of the blue-stained submucosal plane for precise dissection. (g) Visualizes the post-resection esophageal ulcer bed showing clear muscularis propria. (h) Presents the final en bloc resected specimen after ex vivo iodine staining, highlighting the irregular tumor margins for pathological assessment. The sequence serves as a gastrointestinal endoscopy educational resource for advanced therapeutic techniques in managing early-stage esophageal squamous cell carcinoma.

A composite of eight endoscopic images (A-H) demonstrating the stepwise procedure of Endoscopic Submucosal Dissection (ESD) for superficial esophageal cancer. (A) White light imaging shows distal esophageal varices marked with a red arrow. (B-C) Visualization of a superficial 0-IIb esophageal lesion using white light and Narrow Band Imaging (NBI), highlighting mucosal irregularity. (D) Magnifying endoscopy with NBI reveals abnormal intraepithelial papillary capillary loops (IPCL), categorized as type B1 and B2, indicative of squamous cell carcinoma. (E) Circumferential electrocautery marking of the lesion's margins for resection guidance. (F-G) Intra-procedural views showing mucosal/submucosal incision and the final post-resection wound surface (ESD ulcer). (H) Placement of a fully covered self-expanding metal stent (SEMS) within the esophageal lumen following the procedure. This series illustrates advanced therapeutic endoscopy techniques for managing early-stage gastrointestinal malignancies in the context of portal hypertension.

A composite of eight endoscopic images (A-H) demonstrating the stepwise procedure of Endoscopic Submucosal Dissection (ESD) for superficial esophageal cancer. (A) White light imaging shows distal esophageal varices marked with a red arrow. (B-C) Visualization of a superficial 0-IIb esophageal lesion using white light and Narrow Band Imaging (NBI), highlighting mucosal irregularity. (D) Magnifying endoscopy with NBI reveals abnormal intraepithelial papillary capillary loops (IPCL), categorized as type B1 and B2, indicative of squamous cell carcinoma. (E) Circumferential electrocautery marking of the lesion's margins for resection guidance. (F-G) Intra-procedural views showing mucosal/submucosal incision and the final post-resection wound surface (ESD ulcer). (H) Placement of a fully covered self-expanding metal stent (SEMS) within the esophageal lumen following the procedure. This series illustrates advanced therapeutic endoscopy techniques for managing early-stage gastrointestinal malignancies in the context of portal hypertension.

A series of six endoscopic clinical photographs (a-f) documenting the step-by-step procedure of Endoscopic Submucosal Tunnel Dissection (ESTD) for a circumferential superficial esophageal neoplastic lesion. (a) Chromoendoscopy using iodine staining highlights patchy, non-staining neoplastic areas against brown-stained healthy mucosa. (b) White circumferential coagulation markings delineate the lesion's boundaries. (c) A complete circumferential mucosal incision is shown, performed using an endoscopic knife at the distal margin. (d) Initiation of a submucosal tunnel, revealing the submucosal layer with visible vasculature. (e) Extended submucosal tunnel creation from an oral-to-anal approach, maintaining a stable dissection plane between the mucosa and muscularis propria. (f) Final post-resection view showing a large artificial ulcer after en bloc removal of the lesion. The series demonstrates advanced interventional gastroenterology techniques used to treat extensive esophageal neoplasia while preserving luminal integrity and minimizing procedural time compared to conventional endoscopic submucosal dissection (ESD).

A series of six endoscopic clinical photographs (a-f) documenting the step-by-step procedure of Endoscopic Submucosal Tunnel Dissection (ESTD) for a circumferential superficial esophageal neoplastic lesion. (a) Chromoendoscopy using iodine staining highlights patchy, non-staining neoplastic areas against brown-stained healthy mucosa. (b) White circumferential coagulation markings delineate the lesion's boundaries. (c) A complete circumferential mucosal incision is shown, performed using an endoscopic knife at the distal margin. (d) Initiation of a submucosal tunnel, revealing the submucosal layer with visible vasculature. (e) Extended submucosal tunnel creation from an oral-to-anal approach, maintaining a stable dissection plane between the mucosa and muscularis propria. (f) Final post-resection view showing a large artificial ulcer after en bloc removal of the lesion. The series demonstrates advanced interventional gastroenterology techniques used to treat extensive esophageal neoplasia while preserving luminal integrity and minimizing procedural time compared to conventional endoscopic submucosal dissection (ESD).

A series of eight endoscopic clinical photographs (a-h) illustrating the step-by-step Endoscopic Submucosal Dissection (ESD) procedure in the gastrointestinal tract. (a) Displays the initial gastric or esophageal lesion under white light endoscopy, characterized by mucosal irregularity and erythema. (b) Shows Narrow Band Imaging (NBI) used to identify and mark the lateral margins of the lesion. (c) Visualizes the circumferential mucosal incision. (d) Demonstrates active submucosal dissection using an electrosurgical knife to separate the lesion from the deeper muscular layer. (e) Shows intraprocedural hemostasis of a bleeding vessel using hot biopsy forceps. (f) Displays the post-resection artificial ulcer base after complete en bloc removal. (g) Identifies an intraprocedural complication involving visible damage to the muscularis propria layer. (h) Illustrates the therapeutic management of the complication, where mechanical endoscopic clips are used to close the muscularis propria defect to prevent luminal perforation. This series serves as an educational resource for gastroenterology trainees to understand ESD stages, instrument usage, and complication management.

A series of eight endoscopic clinical photographs (a-h) illustrating the step-by-step Endoscopic Submucosal Dissection (ESD) procedure in the gastrointestinal tract. (a) Displays the initial gastric or esophageal lesion under white light endoscopy, characterized by mucosal irregularity and erythema. (b) Shows Narrow Band Imaging (NBI) used to identify and mark the lateral margins of the lesion. (c) Visualizes the circumferential mucosal incision. (d) Demonstrates active submucosal dissection using an electrosurgical knife to separate the lesion from the deeper muscular layer. (e) Shows intraprocedural hemostasis of a bleeding vessel using hot biopsy forceps. (f) Displays the post-resection artificial ulcer base after complete en bloc removal. (g) Identifies an intraprocedural complication involving visible damage to the muscularis propria layer. (h) Illustrates the therapeutic management of the complication, where mechanical endoscopic clips are used to close the muscularis propria defect to prevent luminal perforation. This series serves as an educational resource for gastroenterology trainees to understand ESD stages, instrument usage, and complication management.

This endoscopic clinical photograph depicts a key step in Endoscopic Submucosal Dissection (ESD) of a superficial esophageal squamous cell carcinoma (SCC). The image shows the initial mucosal incision phase. Centrally, a circular transparent distal hood (cap) is attached to the endoscope to maintain a stable field of view and provide tissue tension. A circumferential mucosal incision is visible, characterized by a sharp boundary where the mucosal layer has been cut, exposing the underlying whitish-yellow submucosal layer. The surrounding esophageal mucosa appears erythematous and slightly edematous, consistent with the procedural trauma and inflammatory response. The lumen beyond the lesion is visible as a dark aperture. This stage is critical for defining the lateral margins of the en bloc resection, allowing subsequent dissection of the submucosa to separate the lesion from the muscularis propria.

This endoscopic clinical photograph depicts a key step in Endoscopic Submucosal Dissection (ESD) of a superficial esophageal squamous cell carcinoma (SCC). The image shows the initial mucosal incision phase. Centrally, a circular transparent distal hood (cap) is attached to the endoscope to maintain a stable field of view and provide tissue tension. A circumferential mucosal incision is visible, characterized by a sharp boundary where the mucosal layer has been cut, exposing the underlying whitish-yellow submucosal layer. The surrounding esophageal mucosa appears erythematous and slightly edematous, consistent with the procedural trauma and inflammatory response. The lumen beyond the lesion is visible as a dark aperture. This stage is critical for defining the lateral margins of the en bloc resection, allowing subsequent dissection of the submucosa to separate the lesion from the muscularis propria.

This composite of six endoscopic images (A-F) illustrates the progression and surveillance of superficial esophageal squamous cell carcinoma (SESCC) post-endoscopic submucosal dissection (ESD), categorized by Lugol staining patterns. Images A and D show primary lesions: Type A background (A) displays a uniform pinkish-red hue, while Type D background (D) exhibits numerous irregular Lugol-void lesions (LVLs) with a variegated appearance. Image B shows the intraoperative ESD procedure. Image C demonstrates a successful post-procedural outcome with a smooth, homogeneous orange-red scar indicating no recurrence. In contrast, images E and F depict high-risk surveillance findings; image E shows a background with extensive LVLs (Type D), and image F demonstrates a metachronous recurrence, characterized by a textured, heterogeneous elevation and abnormal mucosal color compared to the primary scar tissue. This series highlights the clinical significance of Lugol chromoendoscopy in identifying high-risk mucosal backgrounds prone to metachronous esophageal cancer.

This composite of six endoscopic images (A-F) illustrates the progression and surveillance of superficial esophageal squamous cell carcinoma (SESCC) post-endoscopic submucosal dissection (ESD), categorized by Lugol staining patterns. Images A and D show primary lesions: Type A background (A) displays a uniform pinkish-red hue, while Type D background (D) exhibits numerous irregular Lugol-void lesions (LVLs) with a variegated appearance. Image B shows the intraoperative ESD procedure. Image C demonstrates a successful post-procedural outcome with a smooth, homogeneous orange-red scar indicating no recurrence. In contrast, images E and F depict high-risk surveillance findings; image E shows a background with extensive LVLs (Type D), and image F demonstrates a metachronous recurrence, characterized by a textured, heterogeneous elevation and abnormal mucosal color compared to the primary scar tissue. This series highlights the clinical significance of Lugol chromoendoscopy in identifying high-risk mucosal backgrounds prone to metachronous esophageal cancer.

This composite of clinical endoscopic images demonstrates a step-by-step endoscopic submucosal dissection (ESD) for a gastric dysplasia lesion. The initial frames show the identification of the target lesion, where 0.1% indigo carmine dye has been applied to delineate the margins and surface morphology. The subsequent frames illustrate the active dissection phase: a circumferential mucosal incision is performed using an IT knife (electrosurgical generator), followed by the dissection of the submucosal layer to separate the lesion from the underlying muscularis propria. The visualization shows the 'lifting' of the mucosal layer away from the deeper gastric wall, exposing a clean, white submucosal base. The final frame depicts the pathological specimen after en bloc resection, pinned out on a dark board with surgical pins to maintain its orientation and size for histological examination. This procedure is critical in managing high-grade dysplasia (HGD) or early gastric cancer, allowing for complete removal with lower local recurrence rates compared to piecemeal resection techniques.

This composite of clinical endoscopic images demonstrates a step-by-step endoscopic submucosal dissection (ESD) for a gastric dysplasia lesion. The initial frames show the identification of the target lesion, where 0.1% indigo carmine dye has been applied to delineate the margins and surface morphology. The subsequent frames illustrate the active dissection phase: a circumferential mucosal incision is performed using an IT knife (electrosurgical generator), followed by the dissection of the submucosal layer to separate the lesion from the underlying muscularis propria. The visualization shows the 'lifting' of the mucosal layer away from the deeper gastric wall, exposing a clean, white submucosal base. The final frame depicts the pathological specimen after en bloc resection, pinned out on a dark board with surgical pins to maintain its orientation and size for histological examination. This procedure is critical in managing high-grade dysplasia (HGD) or early gastric cancer, allowing for complete removal with lower local recurrence rates compared to piecemeal resection techniques.

This endoscopic clinical photograph depicts the stages of endoscopic submucosal dissection (ESD) performed on an esophageal lesion following prior radiofrequency ablation (RFA). Image (a) shows the post-RFA mucosal environment, characterized by pink tissue with interspersed white, irregular patches indicating mild submucosal fibrosis and thermal effect. Image (b) demonstrates the procedural step of submucosal elevation. A glycerol solution mixed with indigo carmine dye (blue) has been injected, successfully expanding the submucosal space and creating a distinct blue-tinged cushion. This elevation facilitates the dissection of the target tissue from deeper muscular layers. The content illustrates management strategies for residual or recurrent superficial esophageal squamous cell neoplasia (SESCN), highlighting how ESD can overcome RFA-induced fibrosis through deep submucosal plane dissection. The visual is intended for intermediate to advanced gastroenterology training, focusing on therapeutic endoscopy techniques and tissue response to thermal ablation.

This endoscopic clinical photograph depicts the stages of endoscopic submucosal dissection (ESD) performed on an esophageal lesion following prior radiofrequency ablation (RFA). Image (a) shows the post-RFA mucosal environment, characterized by pink tissue with interspersed white, irregular patches indicating mild submucosal fibrosis and thermal effect. Image (b) demonstrates the procedural step of submucosal elevation. A glycerol solution mixed with indigo carmine dye (blue) has been injected, successfully expanding the submucosal space and creating a distinct blue-tinged cushion. This elevation facilitates the dissection of the target tissue from deeper muscular layers. The content illustrates management strategies for residual or recurrent superficial esophageal squamous cell neoplasia (SESCN), highlighting how ESD can overcome RFA-induced fibrosis through deep submucosal plane dissection. The visual is intended for intermediate to advanced gastroenterology training, focusing on therapeutic endoscopy techniques and tissue response to thermal ablation.

Here are real endoscopic procedure photos showing every step of ESD for esophageal squamous cell carcinoma:

ESD Procedure - Step by Step with Real Photos


πŸ”΄ STEP 1 β€” Find the Cancer with Iodine Staining + Mark the Borders

Lugol's iodine is sprayed inside the esophagus. Normal tissue stains dark brown. Cancer tissue stays orange/unstained. The surgeon marks dots all around the edge of the cancer.
Step 1: Lugol's iodine chromoendoscopy shows the unstained (orange) cancer area; white cautery dots mark the resection boundary. Steps b-c show the first mucosal incisions being made around the lesion.

🟑 STEP 2 β€” Identify the Cancer Borders Under Special Light (NBI)

Narrow Band Imaging (NBI) shows abnormal blood vessel patterns inside the cancer tissue, confirming the exact edges before cutting.
Steps A-D: White light view, then NBI showing mucosal irregularity, then magnified NBI revealing abnormal blood vessel loops (B1/B2 type) confirming squamous cell carcinoma, then cautery marking of margins

🟒 STEP 3 β€” Inject Fluid to Lift the Lesion + Make the Cut

Fluid (blue-coloured) is injected under the cancer to lift it away from the muscle wall. The surgeon then makes a circular cut around the entire lesion.
Close-up of the critical mucosal incision step: the circular cut has been made around the lesion, exposing the white-yellow submucosal layer underneath, ready for dissection

πŸ”΅ STEP 4 β€” Tunnel Under the Lesion and Remove It

The surgeon cuts underneath the lesion, separating it from the muscle layer. A "tunnel" is created beneath the cancer so it can be removed in one complete piece.
Steps a-f: Iodine marks the cancer, boundary dots placed, circular incision made, submucosal tunnel initiated showing blood vessels of submucosal layer, tunnel extended oral-to-anal direction, final large post-resection ulcer bed after en bloc removal

🟣 STEP 5 β€” Full Dissection, Bleeding Control, Clip if Needed

During cutting, any bleeding vessels are sealed with hot forceps. If a small hole occurs in the muscle wall, metal clips close it immediately.
Full 8-step ESD sequence: a=lesion identification, b=NBI margin marking, c=circumferential incision, d=active submucosal dissection with electrosurgical knife, e=bleeding vessel controlled with hot forceps, f=clean ulcer bed post-removal, g=accidental muscle injury, h=clips applied to close the defect

βœ… STEP 6 β€” The Cancer is Removed (Specimen + Healed Scar)

The removed tissue is pinned flat and sent to the pathologist to confirm clean edges. The raw area left behind heals over 4-6 weeks into a smooth scar.
Left: Post-ESD surveillance showing the healed scar (smooth orange-red area = no cancer remaining). Right: Lugol staining used during follow-up to check for any recurrence - new unstained areas would indicate recurrence

Summary of All 6 Steps

StepWhat HappensPhoto Above
1Iodine staining finds the cancer, borders markedPhoto 1
2NBI confirms exact cancer edgesPhoto 2
3Fluid injected to lift lesion, circular cut madePhoto 3
4Tunnel cut underneath the cancerPhoto 4
5Cancer lifted out, bleeding sealed, clips if neededPhoto 5
6Cancer removed, ulcer heals into clean scarPhoto 6
The entire procedure takes 30-90 minutes. The patient is sedated (asleep). No cuts on the skin. Hospital stay is just 1-3 days. For early-stage cancer like Mrs. Ambika's, this is the most recommended treatment worldwide.
This is a shared conversation. Sign in to Orris to start your own chat.